SCHEMBL5001876

SCHEMBL5001876

CCOC(OC)Oc1cccc(C=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.46
RAB9A P51151 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAOA P21397 7/20 0.43
MAOB P27338 7/20 0.43
ALDH1A1 P00352 2/20 0.42
POLB P06746 2/20 0.42
SRC P12931 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
DRD1 P21728 1/20 0.38
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
MEN1 O00255 1/20 0.36
BLM P54132 1/20 0.36
MCL1 Q07820 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TTR P02766 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7778047 0.92 MAOA (0.47) NPC1RAB9ATDP1MAOAMAOB
SCHEMBL9196727 0.88 NPC1 (0.49) NPC1RAB9ATDP1MAOAMAOB
SCHEMBL25518732 0.83 MAOA (0.47) NPC1RAB9ATDP1MAOAMAOB
SCHEMBL4991362 0.81 ALDH1A3 (0.53) ALDH1A1SMN1; SMN2KDM4EDRD1KMT2A
SCHEMBL10990952 0.79 NPC1 (0.50) NPC1RAB9ATDP1MAOAMAOB
SCHEMBL4990024 0.78 ALDH1A1 (0.49) NPC1RAB9ATDP1ALDH1A1SMN1; SMN2
SCHEMBL7776977 0.77 TP53 (0.42) TDP1MAOBALDH1A1SMN1; SMN2KDM4E
SCHEMBL4998791 0.75 ALDH1A1 (0.47) RAB9AMAOBALDH1A1KDM4EKMT2A
SCHEMBL4996438 0.75 ALDH1A1 (0.58) NPC1RAB9ATDP1ALDH1A1POLB
SCHEMBL17828384 0.75 MAOA (0.48) NPC1RAB9ATDP1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371773-B2 Breast cancer resistance protein (BCRP) inhibitor KABUSHIKI KAISHA YAKULT HONSHA (JP) 2008-05-13 US disclosed
US-20060128636-A1 Breast cancer resistance protein (bcrp) inhibitor KABUSHIKI KAISHA YAKULT HONSHA (JP) 2006-06-15 US disclosed
EP-1591117-A1 BREAST CANCER RESISTANCE PROTEIN (BCRP) INHIBITOR Kabushiki Kaisha Yakult Honsha (JP) 2005-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128636-A1 Breast cancer resistance protein (bcrp) inhibitor ABCC1, OSBP, OSBPL3 NPC1 349/4885RAB9A 4302/4885TDP1 3967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.